Biorecognition Engineering Technologies for Cancer Diagnosis: A Systematic Literature Review of Non-Conventional and Plausible Sensor Development Methods

SIMPLE SUMMARY: Approximately 70% of patients with cancer are diagnosed at late stages of the disease in developing countries. This is partly owed to the restricted access to cost-effective and accurate diagnostic tools in healthcare systems. Biosensor diagnostic tools based on conventional antibodi...

Descripción completa

Detalles Bibliográficos
Autores principales: Mayoral-Peña, Kalaumari, González Peña, Omar Israel, Orrantia Clark, Alexia María, Flores-Vallejo, Rosario del Carmen, Oza, Goldie, Sharma, Ashutosh, De Donato, Marcos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9030888/
https://www.ncbi.nlm.nih.gov/pubmed/35454775
http://dx.doi.org/10.3390/cancers14081867

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9030888/
https://www.ncbi.nlm.nih.gov/pubmed/35454775
http://dx.doi.org/10.3390/cancers14081867

Ejemplares similares